Delivery Order SPE2DB22D3011-SPE2DB24FQ1TB
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. The $1,677.10 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,712,501 units of the ENGERIX-B 20 MCG/ML SYRNML pharmaceutical product. The $50,413.81 firm fixed-price delivery order was awarded on May 24, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 28, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
- This federal contract award, valued at $1,363.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product, with a completion date of May 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of pharmaceutical products and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,655.75 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a completion date of June 11, 2024. Amerisourcebergen, as a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of the medication ENGERIX-B 20 MCG/ML VIALML. The $2,056.29 firm fixed price delivery order was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract has an ultimate completion date of February 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the pharmaceutical product "ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML" to the Defense Logistics Agency (DLA). The firm-fixed-price Delivery Order has a ceiling value of $3,500.38 and a completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the U.S. government. The contract has a ceiling value of $1,693.70 and an ultimate completion date of May 6, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a subdivision of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order (DO) valued at $4,071.00 for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. The contract is a Firm Fixed Price (FFP) arrangement with the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The award has an ultimate completion date of June 7, 2024. Amerisourcebergen...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,751.90 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 5, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a potential value of $2,473.93 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FQ1TBDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product. The $14,626.98 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 6/5/24 |